104 related articles for article (PubMed ID: 38775585)
1. SPONTANEOUS REGRESSION OF HEPATOCELLULAR CARCINOMA: FOCUSING IN THE ASSOCIATED RISK FACTORS.
Tovo CV; Ribas CR; Sartori GDP; Coral GP; Suwa E; Mattos AA
Arq Gastroenterol; 2024; 61():e23151. PubMed ID: 38775585
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous regression of hepatocellular carcinoma.
Kaczynski J; Hansson G; Remotti H; Wallerstedt S
Histopathology; 1998 Feb; 32(2):147-50. PubMed ID: 9543671
[TBL] [Abstract][Full Text] [Related]
3. Development of hepatocellular carcinomas in patients with absence of tumors on a prior ultrasound examination.
Kim KA; Kim MJ; Choi JY; Chung YE
Eur J Radiol; 2012 Jul; 81(7):1450-4. PubMed ID: 21514759
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous regression of hepatocellular carcinoma: A mini-review.
Sakamaki A; Kamimura K; Abe S; Tsuchiya A; Takamura M; Kawai H; Yamagiwa S; Terai S
World J Gastroenterol; 2017 Jun; 23(21):3797-3804. PubMed ID: 28638219
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous complete necrosis of hepatocellular carcinoma: a case report.
Li AJ; Wu MC; Cong WM; Shen F; Yi B
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):152-4. PubMed ID: 14607670
[TBL] [Abstract][Full Text] [Related]
6. Recurrent hepatocellular carcinoma after spontaneous regression.
Lee HS; Lee JS; Woo GW; Yoon JH; Kim CY
J Gastroenterol; 2000; 35(7):552-6. PubMed ID: 10905365
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous complete regression of hepatocellular carcinoma.
Storey RE; Huerta AL; Khan A; Laber DA
Med Oncol; 2011 Dec; 28(4):948-50. PubMed ID: 20467917
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
Ichikawa S; Motosugi U; Enomoto N; Onishi H
Eur Radiol; 2019 Feb; 29(2):1013-1021. PubMed ID: 30043162
[TBL] [Abstract][Full Text] [Related]
9. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
Mariño Z; Darnell A; Lens S; Sapena V; Díaz A; Belmonte E; Perelló C; Calleja JL; Varela M; Rodriguez M; Rodriguez de Lope C; Llerena S; Torras X; Gallego A; Sala M; Morillas RM; Minguez B; Llaneras J; Coll S; Carrion JA; Iñarrairaegui M; Sangro B; Vilana R; Sole M; Ayuso C; Ríos J; Forns X; Bruix J; Reig M
J Hepatol; 2019 May; 70(5):874-884. PubMed ID: 30684506
[TBL] [Abstract][Full Text] [Related]
10. Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?
Huang XW; Liao B; Huang Y; Liang JY; Shan QY; Shen SL; Xie XY; Lu MD; Chen LD; Wang W
Dig Dis; 2018; 36(3):228-235. PubMed ID: 29353268
[TBL] [Abstract][Full Text] [Related]
11. [Survival analysis of patients with spontaneous rupture of hepatocellular carcinoma].
Zhao GG; Xu W; Tian YH; Li DX
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):838-42. PubMed ID: 23206303
[TBL] [Abstract][Full Text] [Related]
12. Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.
Almeida-Carvalho SR; Gomes-Ferraz ML; Loureiro-Matos CA; Benedito-Silva AT; Carvalho-Filho RJ; Renato-Perez R; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
Ann Hepatol; 2017; 16(2):255-262. PubMed ID: 28233747
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.
Ravaioli F; Conti F; Brillanti S; Andreone P; Mazzella G; Buonfiglioli F; Serio I; Verrucchi G; Bacchi Reggiani ML; Colli A; Marasco G; Colecchia A; Festi D
Dig Liver Dis; 2018 Jun; 50(6):573-579. PubMed ID: 29567413
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies.
Randolph AC; Tharalson EM; Gilani N
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):804-9. PubMed ID: 18617788
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of patients with spontaneous rupture of hepatocellular carcinoma in cirrhosis.
Tarantino L; Sordelli I; Calise F; Ripa C; Perrotta M; Sperlongano P
Updates Surg; 2011 Mar; 63(1):25-30. PubMed ID: 21258886
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous regression of hepatocellular carcinomas].
Harada T; Sakaguchi T; Inaba K; Nakamura T; Kurachi K; Fukazawa A; Nakamura K; Sawayanagi T; Hara R; Ida K; Konno H
Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):432-41. PubMed ID: 20203447
[TBL] [Abstract][Full Text] [Related]
20. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Wells ML; Hough DM; Fidler JL; Kamath PS; Poterucha JT; Venkatesh SK
Abdom Radiol (NY); 2017 Nov; 42(11):2623-2631. PubMed ID: 28785785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
